vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and MAGNACHIP SEMICONDUCTOR Corp (MX). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $40.6M, roughly 1.5× MAGNACHIP SEMICONDUCTOR Corp). MAGNACHIP SEMICONDUCTOR Corp runs the higher net margin — -19.9% vs -70.9%, a 51.0% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -20.7%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-4.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -3.4%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Magnachip Semiconductor Corp is a global semiconductor design and manufacturing firm specializing in high-performance analog and mixed-signal solutions. Its core products include display driver ICs, power management ICs and sensors, serving consumer electronics, automotive, industrial and communications markets worldwide.
CTKB vs MX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $40.6M |
| Net Profit | $-44.1M | $-8.1M |
| Gross Margin | 52.9% | 9.3% |
| Operating Margin | -9.0% | -26.1% |
| Net Margin | -70.9% | -19.9% |
| Revenue YoY | 8.1% | -20.7% |
| Net Profit YoY | -557.1% | 50.4% |
| EPS (diluted) | — | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $40.6M | ||
| Q3 25 | $52.3M | $45.9M | ||
| Q2 25 | $45.6M | $47.6M | ||
| Q1 25 | $41.5M | $44.7M | ||
| Q4 24 | $57.5M | $51.2M | ||
| Q3 24 | $51.5M | $55.4M | ||
| Q2 24 | $46.6M | $46.4M | ||
| Q1 24 | $44.9M | $43.4M |
| Q4 25 | $-44.1M | $-8.1M | ||
| Q3 25 | $-5.5M | $-13.1M | ||
| Q2 25 | $-5.6M | $323.0K | ||
| Q1 25 | $-11.4M | $-8.9M | ||
| Q4 24 | $9.6M | $-16.3M | ||
| Q3 24 | $941.0K | $-9.6M | ||
| Q2 24 | $-10.4M | $-13.0M | ||
| Q1 24 | $-6.2M | $-15.4M |
| Q4 25 | 52.9% | 9.3% | ||
| Q3 25 | 52.7% | 18.6% | ||
| Q2 25 | 52.3% | 20.4% | ||
| Q1 25 | 48.6% | 20.9% | ||
| Q4 24 | 58.5% | 21.7% | ||
| Q3 24 | 56.3% | 20.8% | ||
| Q2 24 | 54.6% | 21.1% | ||
| Q1 24 | 51.3% | 14.6% |
| Q4 25 | -9.0% | -26.1% | ||
| Q3 25 | -17.6% | -25.1% | ||
| Q2 25 | -23.3% | -15.6% | ||
| Q1 25 | -36.1% | -14.1% | ||
| Q4 24 | 5.2% | -12.5% | ||
| Q3 24 | -8.2% | -8.1% | ||
| Q2 24 | -18.3% | -12.3% | ||
| Q1 24 | -23.9% | -21.6% |
| Q4 25 | -70.9% | -19.9% | ||
| Q3 25 | -10.5% | -28.5% | ||
| Q2 25 | -12.2% | 0.7% | ||
| Q1 25 | -27.5% | -19.9% | ||
| Q4 24 | 16.8% | -31.8% | ||
| Q3 24 | 1.8% | -17.3% | ||
| Q2 24 | -22.4% | -28.0% | ||
| Q1 24 | -13.8% | -35.5% |
| Q4 25 | — | $-0.23 | ||
| Q3 25 | — | $-0.36 | ||
| Q2 25 | — | $0.01 | ||
| Q1 25 | — | $-0.24 | ||
| Q4 24 | — | $-0.44 | ||
| Q3 24 | — | $-0.26 | ||
| Q2 24 | — | $-0.34 | ||
| Q1 24 | — | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $103.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $248.3M |
| Total Assets | $461.5M | $351.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $103.8M | ||
| Q3 25 | $93.3M | $108.0M | ||
| Q2 25 | $75.5M | $113.3M | ||
| Q1 25 | $95.3M | $132.7M | ||
| Q4 24 | $98.7M | $138.6M | ||
| Q3 24 | $162.3M | $151.1M | ||
| Q2 24 | $177.9M | $162.5M | ||
| Q1 24 | $168.8M | $171.6M |
| Q4 25 | $341.7M | $248.3M | ||
| Q3 25 | $378.6M | $255.3M | ||
| Q2 25 | $377.6M | $270.2M | ||
| Q1 25 | $379.6M | $269.2M | ||
| Q4 24 | $395.7M | $276.8M | ||
| Q3 24 | $385.5M | $299.6M | ||
| Q2 24 | $389.1M | $305.8M | ||
| Q1 24 | $392.6M | $321.9M |
| Q4 25 | $461.5M | $351.5M | ||
| Q3 25 | $494.9M | $359.6M | ||
| Q2 25 | $493.3M | $370.5M | ||
| Q1 25 | $482.6M | $373.9M | ||
| Q4 24 | $499.5M | $379.3M | ||
| Q3 24 | $491.2M | $411.4M | ||
| Q2 24 | $483.7M | $412.7M | ||
| Q1 24 | $492.1M | $426.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $5.4M |
| Free Cash FlowOCF − Capex | $-1.8M | $-4.8M |
| FCF MarginFCF / Revenue | -2.9% | -11.9% |
| Capex IntensityCapex / Revenue | 1.6% | 25.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-54.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $5.4M | ||
| Q3 25 | $-3.9M | $162.0K | ||
| Q2 25 | $108.0K | $-25.1M | ||
| Q1 25 | $-125.0K | $-4.7M | ||
| Q4 24 | $2.0M | $11.9M | ||
| Q3 24 | $13.2M | $-12.9M | ||
| Q2 24 | $6.2M | $-1.1M | ||
| Q1 24 | $4.0M | $-4.0M |
| Q4 25 | $-1.8M | $-4.8M | ||
| Q3 25 | $-4.6M | $-7.5M | ||
| Q2 25 | $-1.5M | $-37.0M | ||
| Q1 25 | $-974.0K | $-4.9M | ||
| Q4 24 | $1.1M | $4.4M | ||
| Q3 24 | $12.2M | $-15.5M | ||
| Q2 24 | $5.2M | $-2.0M | ||
| Q1 24 | $3.4M | $-4.6M |
| Q4 25 | -2.9% | -11.9% | ||
| Q3 25 | -8.7% | -16.3% | ||
| Q2 25 | -3.2% | -77.7% | ||
| Q1 25 | -2.3% | -10.9% | ||
| Q4 24 | 1.9% | 8.7% | ||
| Q3 24 | 23.7% | -28.0% | ||
| Q2 24 | 11.0% | -4.3% | ||
| Q1 24 | 7.6% | -10.7% |
| Q4 25 | 1.6% | 25.3% | ||
| Q3 25 | 1.3% | 16.7% | ||
| Q2 25 | 3.5% | 24.9% | ||
| Q1 25 | 2.0% | 0.5% | ||
| Q4 24 | 1.6% | 14.5% | ||
| Q3 24 | 2.0% | 4.7% | ||
| Q2 24 | 2.3% | 1.9% | ||
| Q1 24 | 1.3% | 1.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -77.81× | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
MX
| Power Analog Solutions | $36.8M | 91% |
| Power Ic | $3.8M | 9% |
